Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The main objective of this phase 2a proof-of-concept trial is to assess the efficacy of
rotigotine nasal spray in ascending doses in subjects with idiopathic Restless Legs Syndrome.